KYMR - Kymera Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$119.93
DETAILS
HIGH:
$138.00
LOW:
$106.00
MEDIAN:
$119.00
CONSENSUS:
$119.93
UPSIDE:
52.02%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 39.2 | 47.1 | 78.6 | 46.8 | 72.8 | 34.0 | 2.9 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 | 0.2 |
| Gross Profit | 39.2 | 47.1 | 78.6 | 46.8 | 72.8 | 34.0 | 2.1 | (0.2) |
| Operating Expenses | ||||||||
| R&D Expenses | 316.6 | 240.2 | 189.1 | 164.2 | 137.0 | 62.1 | 37.2 | 17.7 |
| SG&A Expenses | 68.2 | 63.5 | 55.0 | 43.8 | 36.3 | 18.2 | 8.0 | 3.8 |
| Other Expenses | 3.8 | 4.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 388.6 | 308.7 | 244.1 | 208.1 | 173.4 | 80.3 | 45.1 | 21.5 |
| Operating Income | ||||||||
| Operating Income | (349.4) | (261.6) | (165.5) | (161.3) | (100.5) | (46.3) | (42.2) | (21.5) |
| Interest Expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Interest Income | 38.0 | 38.0 | 18.8 | 6.6 | 0.5 | 0.8 | 1.0 | 0 |
| Profitability | ||||||||
| EBITDA | (303.1) | (216.2) | (143.2) | (151.7) | (97.6) | (43.7) | (40.4) | (21.2) |
| EBIT | (311.4) | (223.6) | (146.8) | (154.6) | (100.0) | (45.5) | (41.2) | (21.5) |
| Income Before Tax | (311.6) | (223.9) | (147.0) | (154.8) | (100.2) | (45.6) | (41.2) | (21.5) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Net Income | (311.4) | (223.9) | (147.0) | (154.8) | (100.2) | (45.6) | (41.3) | (21.5) |
| Per Share Data | ||||||||
| EPS (Basic) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 | -0.99 | -0.93 | -0.48 |
| EPS (Diluted) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 | -0.99 | -0.93 | -0.48 |
| Shares Outstanding | 84.4 | 75.0 | 58.4 | 53.9 | 48.0 | 44.6 | 44.5 | 44.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 357.0 | 120.3 | 110.0 | 68.4 | 48.0 | 31.0 | 76.0 | 41.3 |
| Short-Term Investments | 491.3 | 368.5 | 264.9 | 338.8 | 394.4 | 265.2 | 15.9 | 0 |
| Net Receivables | 0 | 0.9 | 18.8 | 2.5 | 0.1 | 1.4 | 0 | 0.1 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 22.9 | 20.6 | 11.7 | 9.7 | 0 | 0 | 0 | 0 |
| Total Current Assets | 871.2 | 510.3 | 405.3 | 419.4 | 451.3 | 302.3 | 92.8 | 41.8 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 85.5 | 97.9 | 101.1 | 22.2 | 21.3 | 20.7 | 22.1 | 2.2 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 777.0 | 362.2 | 61.4 | 152.3 | 125.2 | 162.5 | 0 | 0.2 |
| Other Non-Current Assets | 9.1 | 7.7 | 7.9 | 9.1 | 8.1 | 1.6 | 1.8 | 0 |
| Total Non-Current Assets | 871.6 | 467.8 | 170.4 | 183.7 | 154.6 | 184.8 | 23.9 | 2.4 |
| Total Assets | 1,742.8 | 978.0 | 575.8 | 603.1 | 605.9 | 487.2 | 116.7 | 44.2 |
| Current Liabilities | ||||||||
| Account Payables | 4.0 | 6.0 | 7.1 | 4.3 | 4.0 | 4.4 | 3.3 | 2.1 |
| Short-Term Debt | 13.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 22.9 | 13.6 | 37.9 | 35.3 | 61.7 | 92.6 | 23.3 | 2.3 |
| Other Current Liabilities | 24.2 | 35.1 | 23.2 | 0.3 | 0.2 | 0.1 | 0 | 1.3 |
| Total Current Liabilities | 83.2 | 67.8 | 85.7 | 71.3 | 92.5 | 110.6 | 34.6 | 4.7 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0.2 | 0.1 | 0.1 | 109.1 | 73.6 |
| Total Non-Current Liabilities | 79.9 | 74.6 | 95.1 | 41.6 | 53.7 | 92.7 | 156.5 | 74.0 |
| Total Liabilities | 163.1 | 142.4 | 180.8 | 113.0 | 146.3 | 203.3 | 191.1 | 78.7 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (1,066.0) | (754.6) | (530.8) | (383.8) | (229.0) | (128.8) | (76.5) | (35.2) |
| Accumulated Other Comprehensive Income | 1.8 | (1.5) | (0.6) | (4.9) | (0.7) | (0.1) | 0.0 | 0 |
| Total Stockholders' Equity | 1,579.7 | 835.6 | 395.0 | 490.2 | 459.6 | 283.9 | (74.4) | (34.4) |
| Total Liabilities & Equity | 1,742.8 | 978.0 | 575.8 | 603.1 | 605.9 | 487.2 | 116.7 | 44.2 |
| Debt Metrics | ||||||||
| Total Debt | 82.3 | 87.8 | 84.7 | 17.3 | 18.0 | 18.0 | 21.2 | 0.7 |
| Net Debt | (274.8) | (32.5) | (25.3) | (51.1) | (30.0) | (13.0) | (54.8) | (40.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (311.4) | (223.9) | (147.0) | (154.8) | (100.2) | (45.6) | (41.2) | (21.5) |
| Depreciation & Amortization | 8.3 | 7.4 | 3.6 | 3.0 | 2.4 | 1.8 | 0.8 | 0.2 |
| Stock-Based Compensation | 59.9 | 55.0 | 43.1 | 35.5 | 25.0 | 5.2 | 1.2 | 0.6 |
| Change in Working Capital | 15.3 | (24.0) | 9.3 | (37.6) | (61.9) | 124.9 | 2.8 | 2.3 |
| Other Non-Cash Items | (5.0) | (9.1) | (11.8) | 0.9 | 5.8 | 0.3 | 54.3 | 0.4 |
| Operating Cash Flow | (232.9) | (194.5) | (102.8) | (153.1) | (128.9) | 88.1 | 17.9 | (17.9) |
| Investing Activities | ||||||||
| Capital Expenditure | (1.4) | (12.8) | (34.5) | (2.8) | (1.6) | (9.1) | (0.5) | (1.4) |
| Acquisitions | 0 | 0 | 0 | (20.5) | 5.8 | 413.5 | 0 | 0 |
| Purchases of Investments | (1,007.6) | (901.2) | 0 | (446.0) | (456.4) | (529.4) | 0 | 0 |
| Sales/Maturities of Investments | 479.1 | 496.0 | 0 | 469.3 | 358.2 | 115.9 | 0 | 0 |
| Other Investing Activities | 8.9 | 14.0 | 174.4 | 20.5 | (5.8) | (413.5) | (16.0) | 0 |
| Investing Cash Flow | (521.1) | (404.1) | 139.9 | 20.5 | (99.8) | (422.6) | (16.5) | (1.4) |
| Financing Activities | ||||||||
| Net Debt Issuance | (1.5) | (1.6) | (0.1) | (1.1) | (0.8) | (0.6) | (0.4) | (0.3) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 13.8 | 4.3 | 4.3 | 8.0 | 0.2 | 35.3 | 0 |
| Financing Cash Flow | 990.7 | 608.9 | 4.2 | 153.0 | 250.3 | 289.3 | 34.9 | 52.9 |
| Cash Position | ||||||||
| Net Change in Cash | 236.8 | 10.3 | 41.3 | 20.4 | 21.5 | (45.2) | 36.3 | 33.7 |
| Cash at Beginning | 126.0 | 115.8 | 74.5 | 54.1 | 32.6 | 77.8 | 41.5 | 7.7 |
| Cash at End | 362.8 | 126.0 | 115.8 | 74.5 | 54.1 | 32.6 | 77.8 | 41.5 |
| Free Cash Flow | (234.3) | (207.3) | (137.3) | (155.9) | (130.5) | 79.0 | 17.4 | (19.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 39.2 | 47.1 | 78.6 | 46.8 | 72.8 | 34.0 | 2.9 | 0 |
| Gross Profit | 39.2 | 47.1 | 78.6 | 46.8 | 72.8 | 34.0 | 2.1 | (0.2) |
| Operating Income | (349.4) | (261.6) | (165.5) | (161.3) | (100.5) | (46.3) | (42.2) | (21.5) |
| Net Income | (311.4) | (223.9) | (147.0) | (154.8) | (100.2) | (45.6) | (41.3) | (21.5) |
| EPS (Diluted) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 | -0.99 | -0.93 | -0.48 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 357.0 | 120.3 | 110.0 | 68.4 | 48.0 | 31.0 | 76.0 | 41.3 |
| Total Assets | 1,742.8 | 978.0 | 575.8 | 603.1 | 605.9 | 487.2 | 116.7 | 44.2 |
| Total Debt | 82.3 | 87.8 | 84.7 | 17.3 | 18.0 | 18.0 | 21.2 | 0.7 |
| Stockholders' Equity | 1,579.7 | 835.6 | 395.0 | 490.2 | 459.6 | 283.9 | (74.4) | (34.4) |
| Cash Flow | ||||||||
| Operating Cash Flow | (232.9) | (194.5) | (102.8) | (153.1) | (128.9) | 88.1 | 17.9 | (17.9) |
| Capital Expenditure | (1.4) | (12.8) | (34.5) | (2.8) | (1.6) | (9.1) | (0.5) | (1.4) |
| Free Cash Flow | (234.3) | (207.3) | (137.3) | (155.9) | (130.5) | 79.0 | 17.4 | (19.2) |